by Brandon Tudor | Feb 11, 2026 | Blog
Here’s a summary of the Gastroenterology Advisor article “Cannabis Use Linked to Better Hepatic Outcomes, Worse Cardiovascular Outcomes in MASLD” — Key Findings from the Study Population studied: >3.3 million adults hospitalized with MASLD between...
by Brandon Tudor | Feb 3, 2026 | Blog
The HEP Mag article “Closing equity gaps in cirrhosis & liver cancer care” is eye-opening. Summary: Closing Equity Gaps in Cirrhosis and Liver Cancer Care Two new studies from UT Southwestern highlight how trust, communication, health literacy, and access to...
by Brandon Tudor | Jan 27, 2026 | Blog
Here’s a summary of the Diabetes In Control article about GLP-1 drugs and liver disease titled “GLP‑1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C.” 📌 The Core Message GLP-1 receptor agonists — originally developed for type 2 diabetes...
by Brandon Tudor | Jan 22, 2026 | Blog
The European Medical Journal 01/21/2026 article entitled “Both long and short sleep duration linked to liver disease” has new information. Key Findings A recent population-level analysis found that both short and long habitual sleep durations are...
by Brandon Tudor | Jan 18, 2026 | Blog
Liver disease has an effect in the adult patient regarding other conditions. Top 5 Disease States Liver Disease Causes or Exacerbates 1. Cardiovascular Disease (CVD) Most common cause of death in patients with chronic liver disease Liver disease—particularly...